How probiotics affect survival, treatment response, and gut microbiota during cancer therapy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study gives an oral probiotic supplement to adults with confirmed cancer who are receiving cancer therapy and follows them over time. Researchers will track clinical outcomes such as survival and treatment response while measuring changes in the gut microbiota. Stool and clinical data will be collected at scheduled visits to compare microbiome composition and clinical outcomes before and after probiotic use. Participants younger than 20 and pregnant or breastfeeding people are excluded from participation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. age≧20
2. participants with cancer therapy and agree to sign informed consent
3. Cancer confirmed by clinical or pathological diagnosis

Exclusion Criteria:

1. age\<20
2. Pregnant or breastfeeding women

Where it's running

• New Taipei City TuCheng Hospital
  New Taipei City, Taiwan Recruiting

Study contacts

• Principal investigator: Chia-Hsun Hsieh, PhD — Division of Oncology, Chang Gung Memorial Hospital
• Study coordinator: HaoTsai Cheng, PhD
• Email: hautai@cgmh.org.tw
• Phone: 03-3281200

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Probiotics vs Antibiotics as an add-on to non-surgical periodontal care in adult smokers with stage II, grade B periodontitis

  This study tests whether systemic probiotics or systemic antibiotics added to standard non-surgical periodontal treatment help improve gum health in adult smokers with stage II, grade B periodontitis.

  Recruiting October 6 University · Cairo · NCT07923695

• Photo-based exploration of hope in young people receiving phase 1/2 cancer therapy

  This project will try to understand how young people (ages 12–25) and their caregivers experience and adapt their hope while they are enrolled in phase 1 or 2 cancer therapy using photos and interviews.

  Recruiting St. Jude Children's Research Hospital · Memphis, Tennessee · NCT07444216

• Clostridium butyricum for anxiety and depression in functional dyspepsia

  This trial will test whether taking the probiotic Clostridium butyricum for four weeks can reduce anxiety and depression symptoms in adults with functional dyspepsia.

  Recruiting Phase 4 Xijing Hospital of Digestive Diseases · Xi’an, Shanxi · NCT07182890

• Oral Clostridium butyricum to prevent colorectal adenoma recurrence after removal

  This study tests whether a probiotic capsule containing Clostridium butyricum can reduce the chance of colorectal adenomas coming back after they are removed.

  Recruiting at 2 sites Phase 4 The Affiliated Hospital of Qingdao University · Qingdao, Shandong and 1 other locations · NCT07167342

• Coenzyme Q10 toothpaste with daily Limosilactobacillus reuteri probiotics to improve gum health during pregnancy

  For pregnant women with gum disease, this will try whether adding a CoQ10 toothpaste and daily L. reuteri probiotic to regular cleanings reduces plaque and gum bleeding.

  Recruiting University of Pavia · Pavia, Lombardy · NCT07029360

• Probiotics for treating endometriosis

  This study is testing whether taking specific probiotics can help improve gut health and quality of life for people with endometriosis.

  Recruiting The Gut Microbiome Center (Centar za crijevni mikrobiom) · Zagreb · NCT06929364

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.